Transactions
Affichage de - 450 éléments sur 974
-
US$21m
Aptose Biosciences Inc.
Joint Bookrunner (CMPO)
-
US$65m
Bicycle Therapeutics Limited
Lead Manager (IPO)
-
C$128m
Wayland Group
Exclusive Financial Advisor on the sale of its International Business to International Cannabis Corp.
-
N/a
Creativ-Ceutical
Exclusive Financial Advisor (Sell side)
-
US$135m
Fibrocell Science, Inc.
Financial Advisor for Fibrocell Science, Inc. on its collaboration agreement with Castle Creek Pharmaceuticals
-
US$86m
Cortexyme
Co-Manager (IPO)
-
C$29m
Khiron Life Sciences
Co-Lead (Bought Deal)
-
US$230m
CannTrust Holdings Inc.
Joint Bookrunner (Follow-on Offering)
-
US$170m
CannTrust
Co-Manager (Equity Financing)